Article Data

  • Views 456
  • Dowloads 113

Original Research

Open Access

A survey of knowledge and awareness of Jordanian female university students of human papillomavirus infection and its vaccine

  • I. Lataifeh1,*,
  • H. Al Chalabi1
  • N. Faleh2
  • L. Yousef2
  • M. Al Jallad3
  • Y. Asfour1

1Department of Obstetrics and Gynecology, Jordan University of Science and Technology, Irbid, Jordan

2Department of Obstetrics and Gynecology, Islamic Hospital, Amman, Jordan

3Department of Obstetrics and Gynecology, Specialty Hospital, Amman, Jordan

DOI: 10.12892/ejgo3293.2016 Vol.37,Issue 6,December 2016 pp.796-799

Published: 10 December 2016

*Corresponding Author(s): I. Lataifeh E-mail: isam_l@yahoo.com

Abstract

Objective: To assess the knowledge and awareness of Jordanian female university students regarding human papillomavirus (HPV) infection and its vaccine. Materials and Methods: A self-administered, anonymous questionnaire was distributed to 450 participants at Jordan University of Science and Technology (JUST) in Jordan. The survey focused on three areas: knowledge and awareness of HPV infection, knowledge of HPV vaccine, and source of information about HPV infection and its vaccine. Results: The survey response rate was 79.8%. Most of the respondents (about 68%) have heard about HPV and knew that the HPV is a virus in the genital area that is sexually transmitted, and 59% of them knew that persistent infection with HPV virus can cause precancerous/cancerous diseases in the genital tract. Only 45% of the respondents have ever heard about HPV vaccine and 37.8% of them knew that HPV vaccine is very effective in preventing HPV infection and its related precancerous/cancerous diseases. Majority of the respondents, 78.7 % and 73.5%, who knew about HPV and HPV vaccine, respectively, had heard about it from healthcare providers. Conclusion: The study suggests that more health education and information about the HPV characteristics and HPV vaccine is needed for female university students.

Keywords

Awareness; Human papillomavirus; Knowledge; university; Vaccine.

Cite and Share

I. Lataifeh,H. Al Chalabi,N. Faleh,L. Yousef,M. Al Jallad,Y. Asfour. A survey of knowledge and awareness of Jordanian female university students of human papillomavirus infection and its vaccine. European Journal of Gynaecological Oncology. 2016. 37(6);796-799.

References

[1] Globocan 2012: “Estimated cancer incidence, mortality and prevalence worldwide in 2012”. Available at: http://globocan.iarc.fr/Default.aspx

[2] Wilson C.M., Tobin S., Young R.C.: “The exploding worldwidecancer burden: the impact of cancer on women”. Int. J. Gynecol. Cancer, 2004, 14, 1.

[3] Pitts M., Clarke T.: “Human papilomavirus infections and risks of cervical cancer:what do women know?” Health Edu. Res., 2002, 17, 706.

[4] Mistro A., Salamanca H., Trevisan R., Bertorelle R., Parenti A., Bonoldi E., et al.: “Human papillomavirus typing of invasive cervical cancers in Italy”. Infect. Agent Cancer, 2006, 1, 9.

[5] Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S.: “Persistent human papillomavirus infection and cervical neoplasia: a systematic review and metaanalysis”. Am. J. Epidemiol., 2008, 168, 123.

[6] Hausen H.: “Papillomaviruses and cancer: from basic studies to clinical application”. Nat. Rev. Cancer, 2002, 2, 342.

[7] Richardson H., Abrahamowicz M., Tellier P.P., Kelsall G., Berger R., Ferenczy A., et al.: “Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1149.

[8] Matos A., Moutinho J., Pinto D., Medeiros R.: ‘The influence of smoking and othercofactors on the time to onset cervical cancer in a southern European population”. Eur. J. Cancer Prev., 2005, 14, 485.

[9] Wong L.P., Sam I.C.: “Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV) vaccination and cervical cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 148, 90.

[10] Dell D.L., Chen H., Ahmad F., Stewart D.E.: “Knowledge about human papillomavirus among adolescents”. Obstet. Gynecol., 1990, 96, 653.

[11] Mays R.M., Zimet G.D., Winston Y., Kee R., Dickes J., Su L.: “Human papillomavirus,genital warts, Pap smears, and cervical cancer: Knowledge and beliefsof adolescent and dult women”. Health Care Women Int., 2000, 21, 361.

[12] Waller J., McCaffery K., Forrest S., Szarewski A., Cadman L., Wardle J.: “Awareness of human papillomavirus among women attending a well woman clinic”. Sex. Transm. Infect., 2003, 79, 320.

[13] Yacobi E., Tennant C., Ferrante J., Pal N., Roetzheim R.: “University students’ knowledge and awareness of HPV”. Prev. Med., 1999, 28, 535.

[14] Gerhardt C.A., Pong K., Kollar L.M., Hillard P.J., Rosenthal S.L.: “Adolescents’ knowledge ofhuman papillomavirus and cervical dysplasia”. J. Pediatr. Adolesc. Gynecol., 2000, 13, 15.

[15] Holcomb B., Bailey J.M., Crawford K., Ruffin M.T. 4th.: “Adults’ knowledge andbehaviors related to human papillomavirus infection”. J. Am. Board Family Pract., 2004, 17, 26.

[16] Ramirez J.E., Ramos D.M., Clayton L., Kanowitz S., Moscicki A.B.: “Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in anonclinic population of young women”. J. Women’s Health, 1997, 6, 113.

[17] Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al.: “Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial”. Lancet, 2004, 364, 1757.

[18] Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., RomanowskiB., Roteli-Martins C.M., et al.: “Sustained efficacy up to 4.5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized controltrial”. Lancet, 2006, 367, 1247.

[19] Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., GiulianoA. R., et al.: “Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 Virus-like particle vaccine in young women: arandomized double-blind placebo-controlled multicenter phase II efficacy trial”. Lancet Oncol., 2005, 6, 271.

[20] Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J.,Iversen O.E., et al.: “High sustained efficacy of a prophylacticquadrivalenthuman papillomavirus types 6/11/16/18 L1 virus-like particle vaccinethrough 5 years of follow-up”. Br. J. Cancer, 2006, 95, 1459.

[21] Boyle P., Levin B.: “World Cancer Report 2008”. Lyon, France: World Health Organization, International Agency for Research on Cancer (IARC), 2008.

[22] Pitts M., Smith A., Croy S., Lyons A., Ryall R., Garland S., et al.: “Singaporean men'sknowledge of cervical cancer and human papillomavirus (HPV) and their attitudestowards HPV vaccination”. Vaccine, 2009, 27, 2989.

[23] Adams M., Jasani B., Fiander A.: “Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening”. Vaccine, 2007, 25, 3007.

[23] Baer H., Allen S., Braun L.: “Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research”. J. Commun. Health, 2000, 25, 67.

[24] McPartland T.S., Weaver B.A., Lee S., Koutsky L.A.: “Men’s perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer”. J. Am. Coll. Health, 2005, 53, 225.

[25] Lambert E.C.: “College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention”. J. Am. Board Fam. Pract.,2001, 14, 178.

[26] Anhang R., Stryker J.E., Wright T.C. Jr., Goldie S.J.: “News media coverage of human papillomavirus”. Cancer, 2004, 100, 308.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top